Emma Hughes

3.2k citations
17 papers · 262 indexed · 1 hit paper · h-index 10

Emma Hughes

17 papers receiving 259 citations

Hit Papers

Pharmacokinetics and safety of once-yearly lenacapavir: a...14202520264812

Peers

Emma Hughes
Comparison fields: 5 of 63
  • Infectious Diseases 143
  • Virology 21
  • Epidemiology 80
  • Hepatology 18
  • Pharmacology 19
Replace Lynne Gilfillan with:
Lynne Gilfillan United States
Yuan Chu China
Tom Holdich United States
Huanying Zhou United States
Elisa Saccon Sweden
André C. Ferreira Brazil
Flora Mikaeloff Sweden
Hans D. Pohle Germany
L Chiappa Italy
Ayyappa Chaturvedula United States
Emma Hughes relative to Lynne Gilfillan United States Lynne Gilfillan's profile →
Citations per field
00.5×5.5×
Lynne Gilfillan · 1×
Citations per year

Countries citing papers authored by Emma Hughes

Since Specialization
Citations

This map shows the geographic impact of Emma Hughes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma Hughes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma Hughes more than expected).

Fields of papers citing papers by Emma Hughes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emma Hughes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma Hughes. The network helps show where Emma Hughes may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Emma Hughes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Emma Hughes Line = papers co-authored together Emma Hughes links everyone, so they are left out of the graph.

All Works

17 of 17 papers shown
#Work
1
Pharmacokinetics and safety of once-yearly lenacapavir: a phase 1, open-label studybreakdown →
202514
2 20251
3 20241
4 20232
5 20226
6 202111
7 20219
8 202110
9 20209
10 202014
11 202081
12 201945
13 201811
14 20174
15 201614
16 201422
17 20138

About Emma Hughes

Emma Hughes is a scholar working on Virology, Infectious Diseases and Hepatology, having authored 17 papers that have together received 262 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (4 papers), Malaria Research and Control (4 papers), HIV Research and Treatment (2 papers), Analytical Chemistry and Chromatography (2 papers), Drug Transport and Resistance Mechanisms (2 papers), Computational Drug Discovery Methods (2 papers), Liver Disease Diagnosis and Treatment (2 papers) and Mosquito-borne diseases and control (2 papers). The work is most often cited by research in Infectious Diseases (143 citations), Virology (21 citations) and Epidemiology (80 citations). Emma Hughes has collaborated with scholars based in United States, Uganda and Tanzania. Frequent co-authors include Erika Wallender, Radojka M. Savić, Francesca Aweeka, Maria Garcia‐Cremades, Anne F. Luetkemeyer, Xin Xu, Nicholas J. Skill, Daniel Raftery, Mary A. Maluccio and Peter R. Williamson. Their work appears in journals such as The Lancet, Nature Communications and Clinical Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026